Specialty Business Services
Compare Stocks
5 / 10Stock Comparison
DLHC vs HCSG vs AMSF vs SGBX vs BLDR
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Care Facilities
Insurance - Specialty
Manufacturing - Metal Fabrication
Construction
DLHC vs HCSG vs AMSF vs SGBX vs BLDR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Specialty Business Services | Medical - Care Facilities | Insurance - Specialty | Manufacturing - Metal Fabrication | Construction |
| Market Cap | $83M | $1.60B | $569M | $33K | $8.79B |
| Revenue (TTM) | $293M | $1.84B | $325M | $3M | $14.82B |
| Net Income (TTM) | $-4M | $59M | $46M | $-19M | $292M |
| Gross Margin | 14.4% | 13.3% | 47.6% | -87.3% | 29.9% |
| Operating Margin | 2.5% | 3.0% | 17.8% | -375.8% | 4.2% |
| Forward P/E | 60.8x | 20.8x | 14.4x | — | 14.1x |
| Total Debt | $145M | $25M | $491K | $7M | $5.65B |
| Cash & Equiv. | $125K | $161M | $62M | $376K | $182M |
DLHC vs HCSG vs AMSF vs SGBX vs BLDR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| DLH Holdings Corp. (DLHC) | 100 | 77.4 | -22.6% |
| Healthcare Services… (HCSG) | 100 | 93.3 | -6.7% |
| AMERISAFE, Inc. (AMSF) | 100 | 49.4 | -50.6% |
| Safe & Green Holdin… (SGBX) | 100 | 0.1 | -99.9% |
| Builders FirstSourc… (BLDR) | 100 | 381.9 | +281.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: DLHC vs HCSG vs AMSF vs SGBX vs BLDR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Among these 5 stocks, DLHC doesn't own a clear edge in any measured category.
HCSG carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 7.1%, EPS growth 52.8%, 3Y rev CAGR 2.8%
- 7.1% revenue growth vs SGBX's -69.9%
- +55.8% vs SGBX's -96.3%
- 7.3% ROA vs SGBX's -35.6%, ROIC 9.0% vs -625.7%
AMSF is the #2 pick in this set and the best alternative if sleep-well-at-night is your priority.
- Lower volatility, beta 0.23, Low D/E 0.2%, current ratio 0.32x
- 14.3% margin vs SGBX's -5.7%
- Beta 0.23 vs BLDR's 1.65, lower leverage
SGBX ranks third and is worth considering specifically for income & stability and defensive.
- Dividend streak 1 yrs, beta 0.45, yield 100.0%
- Beta 0.45, yield 100.0%, current ratio 0.08x
- 100.0% yield, 1-year raise streak, vs AMSF's 8.4%, (3 stocks pay no dividend)
BLDR is the clearest fit if your priority is long-term compounding.
- 6.1% 10Y total return vs AMSF's 31.8%
- Better valuation composite
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 7.1% revenue growth vs SGBX's -69.9% | |
| Value | Better valuation composite | |
| Quality / Margins | 14.3% margin vs SGBX's -5.7% | |
| Stability / Safety | Beta 0.23 vs BLDR's 1.65, lower leverage | |
| Dividends | 100.0% yield, 1-year raise streak, vs AMSF's 8.4%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +55.8% vs SGBX's -96.3% | |
| Efficiency (ROA) | 7.3% ROA vs SGBX's -35.6%, ROIC 9.0% vs -625.7% |
DLHC vs HCSG vs AMSF vs SGBX vs BLDR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
DLHC vs HCSG vs AMSF vs SGBX vs BLDR — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
AMSF leads in 1 of 6 categories
DLHC leads 1 • HCSG leads 1 • SGBX leads 0 • BLDR leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
AMSF leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
BLDR is the larger business by revenue, generating $14.8B annually — 4381.0x SGBX's $3M. AMSF is the more profitable business, keeping 14.3% of every revenue dollar as net income compared to SGBX's -5.7%. On growth, AMSF holds the edge at +10.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $293M | $1.8B | $325M | $3M | $14.8B |
| EBITDAEarnings before interest/tax | $25M | $72M | $58M | -$12M | $1.2B |
| Net IncomeAfter-tax profit | -$4M | $59M | $46M | -$19M | $292M |
| Free Cash FlowCash after capex | $19M | $139M | $8M | -$5M | $862M |
| Gross MarginGross profit ÷ Revenue | +14.4% | +13.3% | +47.6% | -87.3% | +29.9% |
| Operating MarginEBIT ÷ Revenue | +2.5% | +3.0% | +17.8% | -3.8% | +4.2% |
| Net MarginNet income ÷ Revenue | -1.5% | +3.2% | +14.3% | -5.7% | +2.0% |
| FCF MarginFCF ÷ Revenue | +6.5% | +7.6% | +2.5% | -155.0% | +5.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | -33.6% | +6.6% | +10.3% | -40.0% | -10.1% |
| EPS Growth (YoY)Latest quarter vs prior year | -4.0% | +175.0% | -8.5% | +88.9% | -151.2% |
Valuation Metrics
DLHC leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 12.3x trailing earnings, AMSF trades at a 80% valuation discount to DLHC's 60.8x P/E. On an enterprise value basis, DLHC's 6.7x EV/EBITDA is more attractive than HCSG's 22.4x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $83M | $1.6B | $569M | $32,963 | $8.8B |
| Enterprise ValueMkt cap + debt − cash | $228M | $1.5B | $508M | $7M | $14.3B |
| Trailing P/EPrice ÷ TTM EPS | 60.83x | 27.54x | 12.27x | -0.00x | 20.43x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 20.83x | 14.42x | — | 14.07x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | 2.59x |
| EV / EBITDAEnterprise value multiple | 6.71x | 22.38x | 8.53x | — | 10.35x |
| Price / SalesMarket cap ÷ Revenue | 0.24x | 0.87x | 1.80x | 0.01x | 0.58x |
| Price / BookPrice ÷ Book value/share | 0.73x | 3.19x | 2.30x | — | 2.04x |
| Price / FCFMarket cap ÷ FCF | 3.61x | 11.49x | 63.83x | — | 10.30x |
Profitability & Efficiency
Evenly matched — HCSG and AMSF each lead in 5 of 9 comparable metrics.
Profitability & Efficiency
HCSG delivers a 11.8% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-77 for SGBX. AMSF carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to BLDR's 1.30x. On the Piotroski fundamental quality scale (0–9), HCSG scores 7/9 vs SGBX's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -4.0% | +11.8% | +9.7% | -77.2% | +6.9% |
| ROA (TTM)Return on assets | -1.6% | +7.3% | +5.6% | -35.6% | +2.6% |
| ROICReturn on invested capital | +4.7% | +9.0% | +21.9% | -625.7% | +6.4% |
| ROCEReturn on capital employed | +6.6% | +7.7% | +16.8% | — | +8.5% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 | 7 | 2 | 5 |
| Debt / EquityFinancial leverage | 1.28x | 0.05x | 0.00x | — | 1.30x |
| Net DebtTotal debt minus cash | $145M | -$136M | -$61M | $7M | $5.5B |
| Cash & Equiv.Liquid assets | $125,000 | $161M | $62M | $375,873 | $182M |
| Total DebtShort + long-term debt | $145M | $25M | $491,000 | $7M | $5.6B |
| Interest CoverageEBIT ÷ Interest expense | 0.46x | 33.02x | — | -13.81x | 2.19x |
Total Returns (Dividends Reinvested)
HCSG leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BLDR five years ago would be worth $15,180 today (with dividends reinvested), compared to $5 for SGBX. Over the past 12 months, HCSG leads with a +55.8% total return vs SGBX's -96.3%. The 3-year compound annual growth rate (CAGR) favors HCSG at 14.1% vs SGBX's -87.5% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +2.7% | +28.6% | -18.3% | -52.9% | -24.0% |
| 1-Year ReturnPast 12 months | +41.5% | +55.8% | -29.2% | -96.3% | -25.0% |
| 3-Year ReturnCumulative with dividends | -44.1% | +48.6% | -24.8% | -99.8% | -30.1% |
| 5-Year ReturnCumulative with dividends | -44.0% | -21.1% | -18.9% | -100.0% | +51.8% |
| 10-Year ReturnCumulative with dividends | +24.0% | -26.8% | +31.8% | -100.0% | +614.8% |
| CAGR (3Y)Annualised 3-year return | -17.6% | +14.1% | -9.1% | -87.5% | -11.2% |
Risk & Volatility
Evenly matched — HCSG and AMSF each lead in 1 of 2 comparable metrics.
Risk & Volatility
AMSF is the less volatile stock with a 0.23 beta — it tends to amplify market swings less than BLDR's 1.65 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HCSG currently trades 91.5% from its 52-week high vs SGBX's 1.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.82x | 1.12x | 0.23x | 0.45x | 1.65x |
| 52-Week HighHighest price in past year | $8.10 | $24.39 | $48.54 | $96.00 | $151.03 |
| 52-Week LowLowest price in past year | $3.95 | $12.66 | $29.42 | $0.79 | $73.40 |
| % of 52W HighCurrent price vs 52-week peak | +70.7% | +91.5% | +62.4% | +1.0% | +52.6% |
| RSI (14)Momentum oscillator 0–100 | 45.4 | 61.8 | 34.2 | 35.2 | 42.8 |
| Avg Volume (50D)Average daily shares traded | 8K | 676K | 212K | 503K | 2.4M |
Analyst Outlook
Evenly matched — HCSG and SGBX each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: HCSG as "Hold", AMSF as "Buy", BLDR as "Buy". Consensus price targets imply 46.9% upside for AMSF (target: $45) vs 9.8% for HCSG (target: $25). For income investors, SGBX offers the higher dividend yield at 100.00% vs AMSF's 8.41%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Buy | — | Buy |
| Price TargetConsensus 12-month target | — | $24.50 | $44.50 | — | $109.92 |
| # AnalystsCovering analysts | — | 15 | 6 | — | 43 |
| Dividend YieldAnnual dividend ÷ price | — | — | +8.4% | +100.0% | — |
| Dividend StreakConsecutive years of raises | 1 | 20 | 0 | 1 | 2 |
| Dividend / ShareAnnual DPS | — | — | $2.55 | $13.85 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +3.9% | +2.1% | 0.0% | +4.7% |
AMSF leads in 1 of 6 categories (Income & Cash Flow). DLHC leads in 1 (Valuation Metrics). 3 tied.
DLHC vs HCSG vs AMSF vs SGBX vs BLDR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is DLHC or HCSG or AMSF or SGBX or BLDR a better buy right now?
For growth investors, Healthcare Services Group, Inc.
(HCSG) is the stronger pick with 7. 1% revenue growth year-over-year, versus -69. 9% for Safe & Green Holdings Corp. (SGBX). AMERISAFE, Inc. (AMSF) offers the better valuation at 12. 3x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate AMERISAFE, Inc. (AMSF) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — DLHC or HCSG or AMSF or SGBX or BLDR?
On trailing P/E, AMERISAFE, Inc.
(AMSF) is the cheapest at 12. 3x versus DLH Holdings Corp. at 60. 8x. On forward P/E, Builders FirstSource, Inc. is actually cheaper at 14. 1x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — DLHC or HCSG or AMSF or SGBX or BLDR?
Over the past 5 years, Builders FirstSource, Inc.
(BLDR) delivered a total return of +51. 8%, compared to -100. 0% for Safe & Green Holdings Corp. (SGBX). Over 10 years, the gap is even starker: BLDR returned +614. 8% versus SGBX's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — DLHC or HCSG or AMSF or SGBX or BLDR?
By beta (market sensitivity over 5 years), AMERISAFE, Inc.
(AMSF) is the lower-risk stock at 0. 23β versus Builders FirstSource, Inc. 's 1. 65β — meaning BLDR is approximately 616% more volatile than AMSF relative to the S&P 500. On balance sheet safety, AMERISAFE, Inc. (AMSF) carries a lower debt/equity ratio of 0% versus 130% for Builders FirstSource, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — DLHC or HCSG or AMSF or SGBX or BLDR?
By revenue growth (latest reported year), Healthcare Services Group, Inc.
(HCSG) is pulling ahead at 7. 1% versus -69. 9% for Safe & Green Holdings Corp. (SGBX). On earnings-per-share growth, the picture is similar: Safe & Green Holdings Corp. grew EPS 69. 1% year-over-year, compared to -81. 5% for DLH Holdings Corp.. Over a 3-year CAGR, HCSG leads at 2. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — DLHC or HCSG or AMSF or SGBX or BLDR?
AMERISAFE, Inc.
(AMSF) is the more profitable company, earning 14. 9% net margin versus -341. 2% for Safe & Green Holdings Corp. — meaning it keeps 14. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AMSF leads at 18. 6% versus -195. 0% for SGBX. At the gross margin level — before operating expenses — AMSF leads at 46. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is DLHC or HCSG or AMSF or SGBX or BLDR more undervalued right now?
On forward earnings alone, Builders FirstSource, Inc.
(BLDR) trades at 14. 1x forward P/E versus 20. 8x for Healthcare Services Group, Inc. — 6. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AMSF: 46. 9% to $44. 50.
08Which pays a better dividend — DLHC or HCSG or AMSF or SGBX or BLDR?
In this comparison, SGBX (100.
0% yield), AMSF (8. 4% yield) pay a dividend. DLHC, HCSG, BLDR do not pay a meaningful dividend and should not be held primarily for income.
09Is DLHC or HCSG or AMSF or SGBX or BLDR better for a retirement portfolio?
For long-horizon retirement investors, AMERISAFE, Inc.
(AMSF) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 23), 8. 4% yield). Builders FirstSource, Inc. (BLDR) carries a higher beta of 1. 65 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (AMSF: +31. 8%, BLDR: +614. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between DLHC and HCSG and AMSF and SGBX and BLDR?
These companies operate in different sectors (DLHC (Unknown) and HCSG (Healthcare) and AMSF (Financial Services) and SGBX (Industrials) and BLDR (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: DLHC is a small-cap quality compounder stock; HCSG is a small-cap quality compounder stock; AMSF is a small-cap deep-value stock; SGBX is a small-cap income-oriented stock; BLDR is a small-cap quality compounder stock. AMSF, SGBX pay a dividend while DLHC, HCSG, BLDR do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.